Clinicopathological Characteristics and Prognoses of Elderly Gastric Cancer Patients after R0 Resection: A Multicenter Study in China

被引:5
|
作者
Ma, Xinfu [1 ]
Ren, Dengfeng [1 ]
Kan, Jie [2 ]
Zheng, Fangchao [1 ,3 ]
Zhang, Shuisheng [4 ,5 ]
Zhang, Yu [6 ]
Li, Yuying [1 ]
Liu, Zhibo [1 ]
Ye, Linhan [1 ,7 ]
Shen, Guoshuang [1 ]
Wang, Ziyi [1 ]
Zhao, Fuxing [1 ]
Ahmad, Raees [1 ]
Zhao, Jiuda [1 ]
机构
[1] Qinghai Univ, Affiliated Canc Hosp, Affiliated Hosp, Dept Med Oncol, Xining 810000, Qinghai, Peoples R China
[2] Peoples Hosp Qinghai Prov, Dept Med Oncol, Xining 810000, Qinghai, Peoples R China
[3] Shouguang Hosp Tradit Chinese Med, Dept Med Oncol, Weifang 261000, Peoples R China
[4] Chinese Acad Med Sci, Natl Canc Ctr, Canc Hosp, Dept Pancreat & Gastr Surg, Beijing 100021, Peoples R China
[5] Peking Union Med Coll, Beijing 100021, Peoples R China
[6] Qinghai Red Cross Hosp, Dept Med Oncol, Xining 810000, Peoples R China
[7] Anhui Prov Hosp, Dept Pain Treatment, Hefei 230000, Anhui, Peoples R China
关键词
gastric cancer; elderly patients; prognosis; gastrectomy; SURGICAL OUTCOMES; ADENOCARCINOMA; YOUNG; GASTRECTOMY; ESOPHAGEAL; STATISTICS; CARCINOMA;
D O I
10.1615/JEnvironPatholToxicolOncol.2018025306
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The number of elderly gastric cancer (GC) patients has been rapidly increasing worldwide, but inadequate understanding regarding elderly GC patients has led to the paucity of appropriate treatment decisions. Our study evaluates clinicopathological characteristics and prognoses of elderly GC patients after R0 resection. Overall, 1877 consecutive GC patients who underwent R0 gastrectomy at four centers were enrolled. We divided patients into three groups according to age: young, middle, and elderly. We then analyzed clinicopathological characteristics and prognoses. Compared to the middle-aged group, the elderly group had a higher male-to-female ratio and number of patients with cardiac GC, trend of more advanced pathological stage, lower ratio of poor to moderate tumor grade, and fewer patients who received adjuvant chemotherapy or chemoradiotherapy. Moreover, 5 yr disease-free survival and overall survival rates of elderly patients were significantly less than those of middle-aged patients. A Cox analysis of middle-aged and elderly patients revealed that age and adjuvant chemotherapy were independent prognostic factors. Adjuvant chemotherapy improved long-term survival of elderly patients with stage III cancer. Elderly GC patients who underwent R0 resection had unique characteristics and poor long-term survival. We found that subjects should be stratified into the three aforementioned age groups when analyzing survival rates of GC patients. In addition, reasonable adjuvant treatment is recommended for elderly patients.
引用
收藏
页码:81 / 91
页数:11
相关论文
共 50 条
  • [41] Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma
    Kattan, MW
    Karpeh, MS
    Mazumdar, M
    Brennan, MF
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) : 3647 - 3650
  • [42] Successful R0 resection after chemotherapy, including nivolumab, for gastric cancer with liver metastases: three case reports
    Kawai, Junpei
    Yasufuku, Itaru
    Fukada, Masahiro
    Asai, Ryuichi
    Sato, Yuta
    Tajima, Yu Jesse
    Saigo, Chiemi
    Kiyama, Shigeru
    Makiyama, Akitaka
    Tanaka, Yoshihiro
    Okumura, Naoki
    Murase, Katsutoshi
    Miyazaki, Tatsuhiko
    Matsuhashi, Nobuhisa
    SURGICAL CASE REPORTS, 2024, 10 (01):
  • [43] Prognostic comparison of the longitudinal margin status in distal bile duct cancer: R0 on first bile duct resection versus R0 after additional resection
    Park, Yejong
    Hwang, Dae Wook
    Kim, Jin Hee
    Hong, Seung-Mo
    Jun, Sun-Young
    Lee, Jae Hoon
    Song, Ki Byung
    Jun, Eun Sung
    Kim, Song Cheol
    Park, Kwang-Min
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2019, 26 (05) : 169 - 178
  • [44] Gastric cancer and intrahepatic cholangiocarcinoma: Gastrectomy followed by left hepatectomy to achieve R0 resection
    Elobu, Alex Emmanuel
    Thorat, Ashok
    Kweyamba, Vianney
    Rai, Rakesh
    FORMOSAN JOURNAL OF SURGERY, 2019, 52 (03) : 107 - 109
  • [45] The effect and therapeutic compliance of adjuvant therapy in patients with cholangiocarcinoma after R0 resection: a retrospective study
    Jeong, Han Taek
    Lee, Joonkee
    Jo, Hyeong Ho
    Kim, Ho Gak
    Han, Jimin
    JOURNAL OF YEUNGNAM MEDICAL SCIENCE, 2023, 40 (01): : 65 - 77
  • [46] Performance of a Nomogram Predicting Disease-specific Survival After an R0 Resection for Gastric Cancer in Patients Receiving Postoperative Chemoradiation therapy
    Verheij, M.
    Dikken, J.
    Coit, D.
    Baser, R.
    Goenen, M.
    Goodman, K.
    Brennan, M.
    Jansen, E.
    Boot, H.
    Van de Velde, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S194 - S194
  • [47] Performance of a Nomogram Predicting Disease-Specific Survival After an R0 Resection for Gastric Cancer in Patients Receiving Postoperative Chemoradiation Therapy
    Dikken, Johan L.
    Coit, Daniel G.
    Baser, Raymond E.
    Goenen, Mithat
    Goodman, Karyn A.
    Brennan, Murray F.
    Jansen, Edwin P. M.
    Boot, Henk
    van de Velde, Cornelis J. H.
    Cats, Annemieke
    Verheij, Marcel
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (03): : 624 - 629
  • [48] EFFECT OF PELVIC IRRADIATION AFTER R0 RESECTION OF METASTATIC RECTAL CANCER.
    Chang, Y.
    Kim, H.
    DISEASES OF THE COLON & RECTUM, 2010, 53 (04) : 611 - 611
  • [49] The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas
    Young Saing Kim
    Sung Yong Oh
    Se-Il Go
    Jung-Hun Kang
    Inkeun Park
    Haa-Na Song
    Jun Ho Ji
    In Gyu Hwang
    Joung-Soon Jang
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 99 - 106
  • [50] Can biomarker examination improve the prognosis of patients with primary lung cancer after R0 lung resection?
    Nakano, Takayuki
    Liu, Dage
    Nakashima, Nariyasu
    Nii, Kazuhito
    Tokunaga, Yoshimasa
    Kita, Yusuke
    Yokomise, Hiroyasu
    CANCER SCIENCE, 2018, 109 : 1107 - 1107